DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Arcotech Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·19 Oct 2026, 7:24 am

Company NSE

Arcotech Limited has informed stock exchanges about the issuance of a certificate under SEBI (Depositories and Participants) Regulations, 2018. This regulatory filing confirms that the company has successfully obtained the necessary compliance certificate from its depository participant. This document verifies that the company's shares are properly listed and dematerialized on the stock exchange, ensuring smooth trading for investors.

For retail investors, this development is a routine administrative update that reinforces the company's adherence to market regulations. It confirms that the company's shares are eligible for trading without any technical or compliance hurdles. This is a standard requirement for listed entities and does not indicate any operational issues or financial distress.

Investors should view this as a routine compliance milestone rather than a significant market-moving event. The stock price is unlikely to be impacted by this specific news. Moving forward, market participants should focus on the company's broader operational performance and quarterly results to gauge its future growth trajectory.